1
|
Shinmura H, Matsushima T, Watanabe A, Shi H, Nagashima A, Takizawa A, Yamada M, Harigane E, Tsunoda Y, Kurashina R, Ichikawa G, Suzuki S. Evaluating the effectiveness of lateral postural management for breech presentation: study protocol for a randomized controlled trial (BRLT study). Trials 2023; 24:360. [PMID: 37245031 PMCID: PMC10225078 DOI: 10.1186/s13063-023-07395-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Accepted: 05/19/2023] [Indexed: 05/29/2023] Open
Abstract
BACKGROUND Breech presentation is observed in 3-4% at term of pregnancy and is one of the leading causes of cesarean section. There is no established treatment for breech presentation before 36 weeks. A retrospective cohort study was conducted to demonstrate that the lateral position is effective for breech presentation. However, there are no randomized controlled trials evaluating lateral position management for breech presentation. Here, we described the methodology of a randomized controlled trial of a cephalic version for breech presentation in the third trimester by lateral postural management (BRLT study). METHODS The BRLT study is an open-label, randomized controlled trial with two parallel groups allocated in a 1:1 ratio to examine the lateral position management for breech presentation, as compared with expectant management care. An academic hospital in Japan will enroll 200 patients diagnosed with a breech presentation by ultrasonography between 28 + 0 weeks and 30 + 0 weeks. Participants in the intervention group will be instructed to lie on their right sides for 15 min three times per day if the fetal back was on the left side or lie on their left sides if the fetal back was on the right side. The instruction will be given every 2 weeks after confirmation of fetal position, and the lateral position will be instructed until the cephalic version, and after the cephalic version, the reverse lateral position will be instructed until delivery. The primary outcome is cephalic presentation at term. The secondary outcomes are cesarean delivery, cephalic presentation 2, 4, and 6 weeks after the instruction, and at delivery, recurrent breech presentation after cephalic version, and adverse effects. DISCUSSION This trial will answer whether the lateral positioning technique is effective in treating breech presentation and, depending on the results, may provide a very simple, less painful, and safe option for treating breech presentation before 36 weeks, and it may impact breech presentation treatment. TRIAL REGISTRATION UMIN Clinical Trials Registry UMIN000043613. Registered on 15 March 2021 https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049800 .
Collapse
Affiliation(s)
- Hiroki Shinmura
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan.
| | - Takashi Matsushima
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Asako Watanabe
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Honglian Shi
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Asako Nagashima
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Ayako Takizawa
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Mayu Yamada
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Eika Harigane
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Youhei Tsunoda
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Ryuhei Kurashina
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Go Ichikawa
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| | - Shunji Suzuki
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, 1-383 Kosugicho, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-8533, Japan
| |
Collapse
|
2
|
Shinmura H, Matsushima T, Okuda N, Watanabe A, Nagashima A, Yamada M, Harigane E, Tsunoda Y, Ichikawa G, Suzuki S. Cephalic version by postural management in the lateral position without the knee-chest position for primiparous breech presentation: A retrospective cohort study. J Obstet Gynaecol Res 2022; 48:703-708. [PMID: 34994031 DOI: 10.1111/jog.15149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Revised: 12/15/2021] [Accepted: 12/29/2021] [Indexed: 11/30/2022]
Abstract
AIM This study aimed to determine the efficacy of postural management in the lateral position for primiparous breech presentation. METHODS A retrospective cohort study was conducted at a single institution from January 2020 through December 2020. Participants were singleton primiparous pregnant women diagnosed with breech presentation between 28 + 0 and 29 + 6 weeks of gestation. The exclusion criteria were scheduled cesarean delivery, uterine malformation, transverse position, and scheduled delivery at another hospital. A doctor instructed the women in the intervention group to lie on their right sides several times a day if the fetal back was on the left side or lie on their left sides if the fetal back was on the right side. The knee-chest position and other methods were not recommended. The control group received expectant management care. The primary endpoint was the percentage of fetuses in a cephalic presentation 2 weeks later. RESULTS Of the 56 women included in the study, 17 women were instructed to lie in the lateral position, and 39 women received expectant management care only. After 2 weeks, women who were instructed to lie in lateral position had a higher rate of fetal cephalic version than the control group (82.4% [14/17] vs. 43.6% [17/39], p = 0.017). No study participants experienced adverse effects. CONCLUSIONS Two weeks of postural management in the lateral position without the knee-chest position significantly reduced the rate of primiparous breech presentation in the third trimester of pregnancy.
Collapse
Affiliation(s)
- Hiroki Shinmura
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Takashi Matsushima
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Naofumi Okuda
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Asako Watanabe
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Asako Nagashima
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Mayu Yamada
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Eika Harigane
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Youhei Tsunoda
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Go Ichikawa
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| | - Shunji Suzuki
- Department of Obstetrics and Gynecology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan
| |
Collapse
|
3
|
Satia I, Nagashima A, Usmani OS. Exploring the role of nerves in asthma; insights from the study of cough. Biochem Pharmacol 2020; 179:113901. [PMID: 32156662 DOI: 10.1016/j.bcp.2020.113901] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Accepted: 03/03/2020] [Indexed: 12/30/2022]
Abstract
Cough in asthma predicts disease severity, prognosis, and is a common and troublesome symptom. Cough is the archetypal airway neuronal reflex, yet little is understood about the underlying neuronal mechanisms. It is generally assumed that symptoms arise because of airway hyper-responsiveness and/or airway inflammation, but despite using inhaled corticosteroids and bronchodilators targeting these pathologies, a large proportion of patients have persistent coughing. This review focuses on the prevalence and impact of cough in asthma and explores data from pre-clinical and clinical studies which have explored neuronal mechanisms of cough and asthma. We present evidence to suggest patients with asthma have evidence of neuronal dysfunction, which is further heightened and exaggerated by both bronchoconstriction and airway eosinophilia. Identifying patients with excessive coughing with asthma may represent a neuro-phenotype and hence developing treatment for this symptom is important for reducing the burden of disease on patients' lives and currently represents a major unmet clinical need.
Collapse
Affiliation(s)
- I Satia
- McMaster University, Department of Medicine, Division of Respirology, Canada; Firestone Institute for Respiratory Health, St Joseph's Hospital, Canada; University of Manchester, Division of Infection, Immunity and Respiratory Medicine, and Manchester Academic Health Science Centre, Manchester, United Kingdom.
| | - A Nagashima
- McMaster University, Department of Medicine, Division of Respirology, Canada
| | | |
Collapse
|
4
|
Sato H, Abe H, Nagashima A, Yokoyama J, Terai S. Gastrointestinal: A rare case of concomitant type III achalasia and chronic idiopathic intestinal pseudo-obstruction. J Gastroenterol Hepatol 2018; 33:559. [PMID: 29469232 DOI: 10.1111/jgh.13980] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Affiliation(s)
- H Sato
- Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan
| | - H Abe
- Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan
| | - A Nagashima
- Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan
| | - J Yokoyama
- Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan
| | - S Terai
- Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan
| |
Collapse
|
5
|
|
6
|
Okamoto T, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tagawa T, Emi Y, Maehara Y. A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB (T > 5cm), II, IIIA non-small cell lung cancer comparing S-1 versus S-1 with cisplatin. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx381.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
7
|
Fukuda T, Oikawa T, Takeji S, Isayama A, Kawano Y, Neyatani Y, Nagashima A, Nishitani T, Konoshima S, Tamai H, Fujita T, Sakamoto Y, Kamada Y, Ide S, Koide Y, Takenaga H, Kurihara K, Sakata S, Ozeki T, Kawamata Y, Miura YM. Advanced Real-Time Feedback Control in JT-60U High Performance Discharges for Application to Fusion Reactor Plasmas. Fusion Science and Technology 2017. [DOI: 10.13182/fst02-a233] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Fukuda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Oikawa
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - S. Takeji
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - A. Isayama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Kawano
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Neyatani
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - A. Nagashima
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Nishitani
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - S. Konoshima
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - H. Tamai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Fujita
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Sakamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Kamada
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - S. Ide
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Koide
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - H. Takenaga
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - K. Kurihara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - S. Sakata
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - T. Ozeki
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. Kawamata
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| | - Y. M. Miura
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment Naka-machi, Naka-gun, Ibaraki-ken 311-0193, Japan
| |
Collapse
|
8
|
Sugie T, Hatae T, Koide Y, Fujita T, Kusama Y, Nishitani T, Isayama A, Sato M, Shinohara K, Asakura N, Konoshima S, Kubo H, Takenaga H, Kawano Y, Kondoh T, Nagashima A, Fukuda T, Sunaoshi H, Naito O, Kitamura S, Tsukahara Y, Sakasai A, Sakamoto Y, Suzuki T, Tobita K, Nemoto M, Morioka A, Ishikawa M, Ishida S, Isei N, Oyama N, Neyatani Y, Itami K, Sakurai S, Tamai H, Tsuchiya K, Higashijima S, Nakano T, Nagaya S, Chiba S, Lee S, Shitomi M. Diagnostics System of JT-60U. Fusion Science and Technology 2017. [DOI: 10.13182/fst02-a242] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- T. Sugie
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Hatae
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Koide
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Fujita
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Kusama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Nishitani
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - A. Isayama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - M. Sato
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - K. Shinohara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - N. Asakura
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Konoshima
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - H. Kubo
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - H. Takenaga
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Kawano
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Kondoh
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - A. Nagashima
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Fukuda
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - H. Sunaoshi
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - O. Naito
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Kitamura
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Tsukahara
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - A. Sakasai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Sakamoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Suzuki
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - K. Tobita
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - M. Nemoto
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - A. Morioka
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - M. Ishikawa
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Ishida
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - N. Isei
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - N. Oyama
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - Y. Neyatani
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - K. Itami
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Sakurai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - H. Tamai
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - K. Tsuchiya
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Higashijima
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - T. Nakano
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Nagaya
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Chiba
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - S. Lee
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| | - M. Shitomi
- Japan Atomic Energy Research Institute, Naka Fusion Research Establishment 801-01 Mukoyama, Naka-machi, Naka-gun, Ibaraki 311-0193, Japan
| |
Collapse
|
9
|
Ishikawa T, Kubota T, Hirose K, Abe H, Nagashima A, Seki K, Honma T, Yoshida T, Ishihara N. BTR May Be Useful Markers for Aggressive Therapy for Primary Hepatic Neuroendocrine Case with Jaundice. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt460.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Hirata H, Nakamura K, Kunitake N, Shioyama Y, Sasaki T, Nonoshita T, Inoue K, Nagashima A, Ono M, Honda H. Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiation Therapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Nagasaka Y, Okada H, Suzuki J, Nagashima A. Absolute Measurements of the Thermal Conductivity of Aqueous NaCl Solutions at Pressures up to 40 MPa. ACTA ACUST UNITED AC 2010. [DOI: 10.1002/bbpc.19830871006] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
12
|
Sugio K, Nagashima A, Nakanishi R, Uchiyama A, Inoue M, Osaki T, Yoshimatsu T, Takenoyama M, Hanagiri T, Yasumoto K. Randomized phase II trial of the biweekly schedule of adjuvant chemotherapy with carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with non-small cell lung cancer (NSCLC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7562 Background: Carboplatin plus paclitaxel and carboplatin plus gemcitabine chemotherapy have shown a good response and an improved survival against advanced NSCLC. This phase II trial assessed the feasibility, safety and efficacy of a bi-weekly schedule for adjuvant chemotherapy. Methods: Patients with completely resected stage IB-IIIB NSCLC were randomized to either carboplatin (AUC3) plus paclitaxel (90mg/m2) (arm A) or carboplatin (AUC3) plus gemcitabine (1000 mg/m2) (arm B), q2w for 8 cycles within 8 weeks after surgery. The main inclusion criteria were no prior chemotherapy or radiotherapy, ECOG PS 0–1, an age of less than 80 years, and an adequate organ function. The primary endpoint was compliance, and secondary endpoints were the disease free survival (DFS) and toxicity. The patients were stratified by gender, histology (adenoca vs. non-adenoca) and disease stage. Results: Between 07/2005 and 06/2007, 76 patients were randomized and 75 were eligible (including 48 males, 27 females; median age 66 years) for intent-to-treat analysis (39 in arm A, 36 in arm B). The histologic types included adenocarcinoma (n=51), squamous cell carcinoma (n=18), large cell carcinoma (n=5), and adenosquamous cell carcinoma (n=1). The pathological stages were IB/IIA/IIB/IIIA/IIIB: 22/10/13/29/1. Twenty-one of 39 pts (54%) in arm A and 25 of 36 pts (69%) in arm B completed 8 cycles, and 59% in arm A and 81% in arm B completed ≥6 cycles. Grade 3/4 hematologic toxicities (%) in arms A/B were respectively; neutropenia 36/53, anemia 0/17, thrombocytopenia 3/0, nausea 3/3. No treatment related deaths were observed. Up to 12/2008, 11 of 39 pts in arm A and 13 of 36 pts in arm B had recurrent disease, but no significant difference was observed. Conclusions: This adjuvant bi- weekly scheduled chemotherapy in both arms resulted in a good compliance and feasible with acceptable levels of toxicity in completely resected NSCLC. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- K. Sugio
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - A. Nagashima
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - R. Nakanishi
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - A. Uchiyama
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - M. Inoue
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - T. Osaki
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - T. Yoshimatsu
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - M. Takenoyama
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - T. Hanagiri
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| | - K. Yasumoto
- University of Occupational & Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medical Center, Kitakyushu, Japan; Shin-Kokura Hospital, Kitakyushu, Japan; Kyushu Kousei Nenkin Hospital, Kitakyushu, Japan; Niigata Rosai Hospital, Joetsu, Japan; Iizuka Hospital, Iizuka, Japan; Fukuoka Wajiro Hospital, Fukuoka, Japan
| |
Collapse
|
13
|
Ono K, Nagashima A, Inaba G, Iwanami T, Yasumoto K. [Postoperative recurrence of spontaneous pneumothorax]. Kyobu Geka 2008; 61:1011-1014. [PMID: 19048897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Few reports on recurrence after thoracoscopic bullectomy for spontaneous pneumothorax specify the follow-up period and follow-up ratio. Because of the variation in follow-up periods, many reported recurrence rates were not comparable. Some reports compared simple recurrence rate (number of recurrent cases/number of operated cases) of different groups with different follow-up periods. In this study, we employ the Kaplan-Meier method along with a set of optimal follow-up periods and ratios in order to determine a more reliable recurrence rate. Consecutive 68 patients (74 surgical procedures) underwent thoracoscopic bullectomy for spontaneous pneumothorax at our institution between November 2000 and December 2005. A follow-up survey was conducted by phone to determine the rate of recurrent pneumothorax. The follow-up ratio and the mean follow-up period were 92.6% and 1,316 +/- 481 days, respectively. Postoperative recurrence was confirmed for 4 patients. The interval up to recurrence was 144, 345, 476 and 616 days after the bullectomy, respectively. All cases of recurrent pneumothorax occurred within 2 years following the bullectomy. The 1-year, 2-year and 3-year cumulative recurrence rate was 3.0%, 6.3% and 6.3%, respectively. In light of these findings, we feel that comparison analysis of pneumothorax recurrence rates should be evaluated using the Kaplan-Meier method, furthermore, our data suggests that a follow-up period of 2 or more years is advisable.
Collapse
Affiliation(s)
- K Ono
- Department of Chest Surgery, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
| | | | | | | | | |
Collapse
|
14
|
Hazama S, Nagashima A, Kondo H, Shimizu R, Araki A, Yoshino S, Okayama N, Hinoda Y, Oka M. A genetic UGT1A1 polymorphism oriented phase I study of irinotecan (CPT-11) and doxifluridine (5’-DFUR: An intermediate form of capecitabine for metastatic colorectal cancer (MCRC). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.3602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
3602 Background: 5-Fluorouracil plus CPT-11 is one of the standard 1st-line therapies in patients (pts) with metastatic colorectal cancer (MCRC). Although it has been reported that individuals carrying the (TA) 7 allele in the TATAA promoter of UGT1A1 increased risk of severe toxic event occurrence after CPT-11 administration, there is no report about phase I study based on the polymorphism of UGT1A1. Here we report the results from a genetic UGT1A1 polymorphism oriented phase I study of CPT-11 and 5’-DFUR to determine the maximum tolerated dose (MTD) and the recommend doses (RD) for each UGT1A1 genotypes. Methods: Eligibility criteria were as follows; histologically proven CRC with unresectable metastatic lesions, PS 0–2, age<76, adequate organ functions, and written informed consent. CPT-11 was infused (level 1, 2, 3 and 4: 70, 100, 120, 150 mg/m2, respectively) biweekly and 5’-DFUR was administered orally (800 mg/body, <1.39 m2; 600 mg/body) on 5 consecutive days with 2 days’ rest for more than 12 weeks. DLT were determined as grade 3 hematological and non-hematological toxicities. Genotypes were determined by analyzing the sequence of TATA box of UGT1A1 of genomic DNA from pts. Results: Eighteen pts with wild 6/6 allele and 9 pts with mutated 6/7 allele were registered. In pts with 6/6 allele, MTD was not observed up to level 4 (150 mg/m2). In pts with mutated 6/7 allele, on the other hand, MTD was observed at level 2 (100 mg/m2). We recommend doses of 70 mg/m2 of CPT-11 for pts with mutated 6/7 allele and 150 mg/m2 of CPT-11 for pts with wild 6/6 allele, respectively. Conclusions: The recommended phases II/III starting doses of biweekly CPT-11 administration are 150 mg/m2 for pts with wild 6/6 allele and 70 mg/m2 of CPT-11 for pts with mutated 6/7 allele, and 5’ -DFUR 800 mg/body on every 5 days per week. This combination therapy may be administered safely for all pts according to the TATAA promoter polymorphism of UGT1A1. The gene polymorphism should be taken into consideration to provide more precise information to guess the individual toxicities. No significant financial relationships to disclose.
Collapse
Affiliation(s)
| | | | - H. Kondo
- Yamaguchi University, Ube, Japan
| | | | - A. Araki
- Yamaguchi University, Ube, Japan
| | | | | | | | - M. Oka
- Yamaguchi University, Ube, Japan
| |
Collapse
|
15
|
Yoshino I, Ichinose Y, Nagashima A, Takeo S, Motohiro A, Yano T, Ishida T, Yamazaki K, Sugio K, Yasumoto K, Maehara Y. Clinical characterization of node-negative non-small cell lung cancer: Results of a prospective investigation. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.7218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7218 Background: 20 to 30% of clinical stage IA non-small cell lung cancer cases were revealed to be node-positive by pathologic examination of resected specimens. In this prospective study, the clinical features of a truly node-negative population were prospectively investigated to search for candidates of a lesser resection or of a stereotactic radiotherapy. Methods: The clinical data and radiographic features of high-resolution computed tomography (HR-CT) were registered before operation in 169 clinical stage IA lung cancer patients, who were scheduled to undergo a standard lobectomy and systemic mediastinal node dissection. The nodal metastasis was pathologically defined, while the clinical factors associated with the presence of the nodal metastasis were evaluated. Results: In 130 evaluable cases, 16 of 114 adenocarcinoma and 3 of 16 other NSCLC were node-positive. Among all parameters, positivity of the serum carcinoembryonic antigen (CEA) was the only factor significantly associated with nodal metastasis (p = 0.0074). When we focused on adenocarcinomas, the serum CEA, retraction sign and intratumoral air-space on HR-CT were suggested to be predictive factors for lymph node metastasis with hazard ratios of 12.44 (p = 0.0003), 6.53 (p = 0.0533) and 0.17 (0.0073), respectively. In combination with the radiologic features of HR-CT imaging, none of 18 CEA-negative/retraction-negative cases and 3 of 65 CEA-negative/air-space positive cases showed nodal metastasis, in which the incidence of nodal metastasis was significantly lower than the counterparts with respective p-values of 0.0015 and 0.037. The tumor size and the proportion of ground glass attenuation were not associated with the incidence of nodal metastasis. Conclusions: The serum CEA and HR-CT features thus allowed us to identify node-negative lung adenocarcinomas. In clinical stage IA adenocarcinoma cases, a standard operation should be considered when positive serum CEA and/or retraction sign on HRCT is noticed. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- I. Yoshino
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - Y. Ichinose
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - A. Nagashima
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - S. Takeo
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - A. Motohiro
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - T. Yano
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - T. Ishida
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - K. Yamazaki
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - K. Sugio
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - K. Yasumoto
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| | - Y. Maehara
- Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; Kyushu Lung Cancer Surgery Cooperative Group, Fukuoka, Japan
| |
Collapse
|
16
|
Sugaya M, Sugio K, Nagashima A, Nakanishi R, Sakata H, Nakanishi K, Ono K, Uramoto H, Hanagiri T, Yasumoto K. Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7258] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. Sugaya
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - K. Sugio
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - A. Nagashima
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - R. Nakanishi
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - H. Sakata
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - K. Nakanishi
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - K. Ono
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - H. Uramoto
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - T. Hanagiri
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| | - K. Yasumoto
- Univ. of Occupational and Environmental Health, Kitakyushu, Japan; Kitakyushu Municipal Medcl Ctr, Kitakyushu, Japan; Shinkokura Hosp, Kitakyushu, Japan; Shinnittetsu Yahata Memorial Hosp, Kitakyushu, Japan; Iizuka Hosp, Iizuka, Japan
| |
Collapse
|
17
|
Nagashima A, Tanaka E, Inomata S, Honda K, Misawa S. A study of the in vitro interaction between lidocaine and premedications using human liver microsomes*. J Clin Pharm Ther 2005; 30:185-8. [PMID: 15811173 DOI: 10.1111/j.1365-2710.2004.00617.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To investigate potential interactions between lidocaine (lignocaine) metabolism and premedication drugs, i.e. psychotropic and antianxiety agents (diazepam, midazolam), hypnotics (pentobarbital, thiamylal), depolarizing neuromuscular blocking agents (vecuronium, pancuronium and suxamethonium), an antihypertensive agent (clonidine) and an H2-receptor blocking agent (cimetidine) using human liver microsomes in vitro. METHODS The interaction effects between lidocaine and premedication were examined using human liver microsomal preparations and monitored for enzyme activity. The lidocaine and its main metabolite (monoethylglycinexylide) were measured by HPLC/UV. RESULTS Lidocaine metabolism was non-competitively inhibited by midazolam (Ki = 77.6 microM). Thiamylal was a competitive inhibitor of lidocaine metabolism (Ki = 885 microM). Cimethidine, pancuronium and vecuronium weakly inhibited lidocaine metabolism in a concentration-depend manner over the therapeutic range in human liver microsomes. On the contrary, suxamethonium, pentobarbital and clonidine did not inhibit lidocaine metabolism over the therapeutic range in human liver microsomes. CONCLUSION These results show that the interactions between lidocaine and midazolam and thiamylal are of potential toxicological and clinical significance.
Collapse
Affiliation(s)
- A Nagashima
- Institute of Community Medicine, University of Tsukuba, Ibaraki-ken, Japan
| | | | | | | | | |
Collapse
|
18
|
Hazama S, Matoba K, Nagashima A, Matsuoka K, Oka M. A phase I study of irinotecan and 5'-DFUR in patients with metastatic colorectal cancer: With consideration of gene polymorphism. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Hazama
- Yamaguchi University School of Medicine, Ube, Japan
| | - K. Matoba
- Yamaguchi University School of Medicine, Ube, Japan
| | - A. Nagashima
- Yamaguchi University School of Medicine, Ube, Japan
| | - K. Matsuoka
- Yamaguchi University School of Medicine, Ube, Japan
| | - M. Oka
- Yamaguchi University School of Medicine, Ube, Japan
| |
Collapse
|
19
|
Nagashima A, Tanak E, Inomata S, Misawa S. A study of the in vitro clinical interaction between lidocaine and premedications using rat liver microsomes. Hum Exp Toxicol 2002; 21:453-6. [PMID: 12412639 DOI: 10.1191/0960327102ht279oa] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
In this study, we have investigated the relationship between lidocaine metabolism and premedication, i.e., psychotropic and anti-anxiety agents (diazepam, midazolam), hypnotics (pentobarbital, thiamylal), depolarizing muscular relaxants (vecuronium, pancuronium and suxamethonium), an active anti-hypertensive (clonidine) and an H2 receptor antagonist (cimetidine) using rat hepatic microsomes in vitro. Lidocaine metabolism was noncompetitively inhibited by midazolam (Ki=29.0 microM). Thilamylal was a moderate competitive inhibitor of lidocaine metabolism (Ki=77.8 microM). Pentobarbital, diazepam and cimetidine weakly inhibited lidocaine metabolism formation in a concentration-dependent manner at high substrate concentrations. On the other hand, vecuronium, pancuronium, suxamethonium and clonidine did not inhibit lidocaine metabolism over the therapeutic range. These results show that the interaction between lidocaine and midazolam and thiamylal, catalyzed by a similar cytochrome P450, is of potential importance in toxicological and clinical studies.
Collapse
Affiliation(s)
- A Nagashima
- Institute of Community Medicine, University of Tsukuba, Japan
| | | | | | | |
Collapse
|
20
|
Matsunaga N, Nagashima A. Prediction of the transport properties of gaseous water and its isotopes at high temperatures. ACTA ACUST UNITED AC 2002. [DOI: 10.1021/j150643a042] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Abstract
The viability and fertility of isolated mouse epididymal spermatozoa kept for up to 7 days at various temperatures (4 degrees C, 22 degrees C, and 37 degrees C) were determined. Spermatozoa kept for 3 days at 22 degrees C were still active, while those kept at 37 degrees C or 4 degrees C exhibited great reduction in motility within 2 days after isolation. In vitro fertilizing abilities of spermatozoa left for 0, 1, 2, and 3 days at 22 degrees C were 69.2, 32.5, 9.5, and 4.9%, respectively, when the cleavage rate to two-cell stage was examined. Transfer of two-cell embryos produced in vitro with spermatozoa left for 1, 2, and 3 days at 22 degrees C resulted in production of fetuses with efficiencies of respectively 30.2, 11.5, and 16.7%, which were lower (63.3%) than that of embryos derived from in vitro fertilization with fresh spermatozoa. These findings indicate that spermatozoa kept for up to 3 days at 22 degrees C can fertilize oocytes, although at relatively low efficiency.
Collapse
Affiliation(s)
- M Sato
- The Institute of Medical Sciences, Tokai University, Bohseidai, Isehara, Kanagawa, Japan.
| | | | | | | | | | | |
Collapse
|
22
|
Sato M, Watanabe T, Oshida A, Nagashima A, Miyazaki JI, Kimura M. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue-specific gene expression. Mol Reprod Dev 2001; 60:446-56. [PMID: 11746955 DOI: 10.1002/mrd.1109] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Identification of transgenics still requires PCR and genomic Southern blot hybridization of genomic DNA isolated from tail pieces. Furthermore, identification of transgene-expressing transgenics (hereafter called "expressor") requires mRNA analyses (RT-PCR and Northern blot hybridization) or protein analysis (Western blotting and immunohistochemical staining using specific antibodies). These approaches are often labor-intensive and time-consuming. We developed a technique that simplifies the process of screening expressor transgenics using enhanced green fluorescent protein (EGFP), a noninvasive reporter recently utilized in a variety of organisms, including mice, as a tag. We constructed a MNCE transgene consisting of two expression units, MBP-NCre (termed "MN") and CAG-EGFP (termed "CE"). MN consists of a myelin basic protein (MBP) promoter and NCre gene (Cre gene carrying a nuclear localization signal (NLS) sequence at its 5' end). CE consists of a promoter element, CAG composed of cytomegalovirus (CMV) enhancer and chicken beta-actin promoter, and EGFP cDNA. Of a total of 72 F0 mice obtained after pronuclear injection of MNCE at 1-cell egg stage, 15 were found to express EGFP when the tail, eye, and inner surface of the ear were inspected for EGFP fluorescence under UV illumination at weaning stage. These fluorescent mice were found to possess MNCE and to express NCre mRNA in a brain-specific manner. Mice exhibiting no fluorescence were transgenic or nontransgenic. Mice carrying MNCE, but exhibiting no fluorescence, never expressed NCre mRNA in any organs tested. These findings indicate that (i) direct inspection of the surface of mice for fluorescence under UV illumination enables identification of expressor transgenics without performances of the molecular biological analyses mentioned above, and (ii) systemic promoters such as CAG do not affect the tissue-specificity of a tissue-specific promoter such as MBP promoter, which is located upstream of CAG by approximately 2 kb.
Collapse
MESH Headings
- Actins/genetics
- Animals
- Blotting, Southern
- Brain/metabolism
- Cells, Cultured
- Chickens/genetics
- Cytomegalovirus/genetics
- DNA, Recombinant/genetics
- Enhancer Elements, Genetic/genetics
- Gene Expression
- Gene Expression Profiling/methods
- Genes, Reporter/genetics
- Green Fluorescent Proteins
- Luminescent Proteins/genetics
- Luminescent Proteins/metabolism
- Mice
- Mice, Transgenic
- Myelin Basic Protein/genetics
- Organ Specificity
- Promoter Regions, Genetic/genetics
- RNA, Messenger/analysis
- RNA, Messenger/genetics
- Recombination, Genetic/genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Transfection
- Transgenes/genetics
Collapse
Affiliation(s)
- M Sato
- Molecular Medicine Research Center, The Institute of Medical Sciences, Tokai University, Bohseidai, Isehara, Kanagawa 259-1193, Japan.
| | | | | | | | | | | |
Collapse
|
23
|
Inomata S, Tanaka E, Miyabe M, Kakiuchi Y, Nagashima A, Yamasaki Y, Nakayama S, Baba Y, Toyooka H, Okuyama K, Kohda Y. Plasma lidocaine concentrations during continuous thoracic epidural anesthesia after clonidine premedication in children. Anesth Analg 2001; 93:1147-51. [PMID: 11682384 DOI: 10.1097/00000539-200111000-00016] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
UNLABELLED There is no report concerning oral clonidine's effects on epidural lidocaine in children. Therefore, we performed a study to assess the concentrations of plasma lidocaine and its major metabolite (monoethylglycinexylidide [MEGX]) in children receiving continuous thoracic epidural anesthesia after oral clonidine premedication. Ten pediatric patients, aged 1-9 yr, were randomly allocated to the Control or Clonidine 4 microg/kg group (n = 5 each). Anesthesia was induced and maintained with sevoflurane in oxygen and air (FIO2 40%). Epidural puncture and tubing were carefully performed at the Th11-12 intervertebral space. An initial dose of 1% lidocaine (5 mg/kg) was injected through a catheter into the epidural space, followed by 2.5 mg x kg(-1) x h(-1). Plasma concentrations of lidocaine and MEGX were measured at 15 min, 30 min, and every 60 min for 4 h after the initiation of continuous epidural injection. The concentrations of lidocaine and MEGX were measured using high-pressure liquid chromatography with ultraviolet detection. Hemodynamic variables were similar between members of the Control and Clonidine groups during anesthesia. The Clonidine group showed significantly smaller lidocaine concentrations (p < 0.05) and the concentration of MEGX tended to be smaller in the plasma of the Clonidine group for the initial 4 h after the initiation of epidural infusion. In conclusion, oral clonidine preanesthetic medication at a dose of 4 microg/kg decreases plasma lidocaine concentration in children. IMPLICATIONS Oral clonidine decreases the plasma lidocaine concentration in children. Our finding may have clinical implications in patients receiving continuous epidural anesthesia. Additionally, perhaps an additional margin of safety regarding lidocaine toxicity is gained through the use of oral clonidine in children who will receive epidural lidocaine.
Collapse
Affiliation(s)
- S Inomata
- Department of Anesthesiology, University of Tsukuba, Tsukuba-shi, Ibaraki-ken, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Hosogai N, Hamada K, Tomita M, Nagashima A, Takahashi T, Sekizawa T, Mizutani T, Urano Y, Kuroda A, Sawada K, Ozaki T, Seki J, Goto T. FR226807: a potent and selective phosphodiesterase type 5 inhibitor. Eur J Pharmacol 2001; 428:295-302. [PMID: 11675048 DOI: 10.1016/s0014-2999(01)01345-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We describe the pharmacological characteristics of a novel phosphodiesterase type 5 inhibitor FR226807, N-(3,4-dimethoxybenzyl)-2-[[(1R)-2-hydroxy-1-methylethyl]amino]-5-nitrobenzamide. FR226807 inhibited phosphodiesterase type 5 isolated from human platelets with an IC(50) value of 1.1 nM. FR226807 also inhibited phosphodiesterase type 6 with an IC(50) of 20 nM; however, the IC(50) value for phosphodiesterase type 6 was 18-fold higher than that for phosphodiesterase type 5. The IC(50) values of FR226807 for other phosphodiesterases (phosphodiesterase type 1, phosphodiesterase type 2, phosphodiesterase type 3, and phosphodiesterase type 4) were 1000-fold higher than that for phosphodiesterase type 5. FR226807 increased the cyclic guanosine monophosphate (cGMP) content in corpus cavernosum isolated from rabbit, an effect associated with relaxation of the muscle. FR226807 enhanced the relaxation response induced by electrical field stimulation of corpus cavernosum isolated from the rabbit. In an anesthetized dog model for the evaluation of erectile function, intravenous administration of FR226807 prolonged the time to return to 75% of maximal intracavernosal pressure after cessation of electrical stimulation of the pelvic nerve. In summary, FR226807 is a potent and highly selective phosphodiesterase type 5 inhibitor with an augmentative effect on penile erection and will be useful for the treatment of erectile dysfunction.
Collapse
Affiliation(s)
- N Hosogai
- Medical Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Yodogawa, Kashima, Osaka 532-8514, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Kanamaru K, Nagashima A, Fujiwara M, Shimada H, Shirano Y, Nakabayashi K, Shibata D, Tanaka K, Takahashi H. An Arabidopsis sigma factor (SIG2)-dependent expression of plastid-encoded tRNAs in chloroplasts. Plant Cell Physiol 2001; 42:1034-43. [PMID: 11673617 DOI: 10.1093/pcp/pce155] [Citation(s) in RCA: 93] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
A eubacteria-type RNA polymerase (PEP) plays crucial roles for chloroplast development in higher plants. The core subunits are encoded on plastid DNA (rpo genes) while the regulatory sigma factors are encoded on the nuclear DNA (SIG genes). However, the definite gene specificity of each sigma factor is unknown. We recently identified an Arabidopsis recessive pale-green mutant abc1 in which T-DNA is inserted in SIG2 (sigB). In this mutant, almost normal etioplasts were developed under dark conditions while the small chloroplasts with poor thylakoid membranes and stacked lamellar were developed under light conditions. The sig2-1 mutant was deficient in accumulating enough photosynthetic and photosynthesis-related proteins as well as chlorophyll. However, mRNAs of their structural genes were not significantly reduced. Further analyses revealed that several plastid-encoded tRNAs including trnE-UUC that has dual function for protein and ALA biosyntheses were drastically reduced in the sig2-1 mutant. In contrast, nucleus-encoded T7 phage-type RNA polymerase (NEP)-dependent gene transcripts were steadily accumulated in the mutant. These results indicate that progress of chloroplast development requires SIG2-dependent expression of plastid genes, particularly some of the tRNA genes.
Collapse
Affiliation(s)
- K Kanamaru
- Laboratory of Molecular Genetics, Department of Molecular Biology, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo, 113-0032 Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Tanaka E, Nakamura T, Nagashima A, Yamazaki K, Ohashi N, Tsuchihashi H, Misawa S. Determination of plasma bromvalerylurea and its main metabolite by a simple high-performance liquid chromatographic method and quantitation of bromide by energy dispersive X-ray spectrometry in carbon tetrachloride-intoxicated rats. J Chromatogr B Biomed Sci Appl 2001; 759:361-6. [PMID: 11499491 DOI: 10.1016/s0378-4347(01)00244-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In the present study, small volumes of plasma were used for the measurement of bromvalerylurea (BVU), its metabolite, 3-methylbutyrylurea (MVU), and bromide in carbon tetrachloride (CCl4)-treated rats by HPLC-UV and energy dispersive X-ray spectrometry. A liquid-liquid extraction system was also investigated. BVU and MVU were extracted from 100 microl plasma samples in a single-step involving deproteination with 1 M hydrochloric acid using ethenzamide as internal standard. Samples were separated by HPLC in an acetonitrile-8 mM potassium dihydrogenphosphate buffer (35:65, v/v) mobile phase at a flow-rate of 0.4 ml/min on a 15 cm octadecylsilyl column at room temperature. Analytes were detected at a wavelength of 210 nm. The limits of quantitation for BVU, MVU and bromide are 0.1, 0.1 and 50 microg/ml, respectively. The intra-day accuracies over the range of concentrations were 95.8 to 121.1%, 97.2 to 119.7% and 96.2 to 105.8% for BVU, MVU and bromide, respectively. The inter-day accuracies were 97.7 to 115.1%, 98.3 to 111.6% and 98.3 to 102.9% for BVU, MVU and bromide, respectively. The absolute recoveries using tert.-butyl methyl ether are 96-98% for BVU and 95-98% for MVU. The decline in the plasma concentrations of BVU in olive oil-treated rats fitted a one-compartment model and the plasma MVU level reached a peak at around 1.5-2 h and then decreased gradually. The elimination of BVU in CCl4 (1 ml/kg)-treated rats was delayed and MVU production was less than that in the olive oil-treated group. However, there was no difference in the plasma levels of bromide between CCl4-treated rats and control rats. rights reserved.
Collapse
Affiliation(s)
- E Tanaka
- Institute of Community Medicine, University of Tsukuba, Ibaraki, Japan.
| | | | | | | | | | | | | |
Collapse
|
27
|
Sato M, Watanabe T, Oshida A, Nagashima A, Miyazaki J, Kimura M. Enhanced green fluorescent protein as a useful tag for rapid identification of homozygous transgenic mice. Biomol Eng 2001; 17:83-5. [PMID: 11222982 DOI: 10.1016/s1389-0344(00)00070-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
We developed a technique that simplifies the process of confirming homozygous transgenics at preimplantation stages, which are the earliest stages used in test breeding, using enhanced green fluorescent protein as a tag. All the blastocysts obtained by mating with the combination of Tg/Tg male (homozygous for transgene) x +/+ female exhibited fluorescence.
Collapse
Affiliation(s)
- M Sato
- Molecular Medicine Research Center, The Institute of Medical Sciences, Tokai University, Bohseidai, Isehara, 259-1193, Kanagawa, Japan.
| | | | | | | | | | | |
Collapse
|
28
|
Takenoyama M, Yoshino I, Eifuku R, So T, Imahayashi S, Sugaya M, Yasuda M, Inoue M, Ichiyoshi Y, Osaki T, Nagashima A, Nomoto K, Yasumoto K. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells. Jpn J Cancer Res 2001; 92:309-15. [PMID: 11267941 PMCID: PMC5926714 DOI: 10.1111/j.1349-7006.2001.tb01096.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Cytotoxic T lymphocytes (CTL) against human lung cancer cells are difficult to induce by a conventional method using tumor cell stimulation probably due to an insufficiency of tumor antigens (TA) or costimulatory molecules such as CD80. We, therefore, investigated the potential of CD80-transfected tumor cells as stimulators of the in vitro induction of autologous tumor-specific CTL from regional lymph node lymphocytes in patients with lung cancer. Five non-small cell lung cancer cell lines (two adenocarcinomas, 1 squamous cell carcinoma, 1 large cell carcinoma and 1 adenosquamous cell carcinoma) were established from surgical specimens and were successfully transduced with a plasmid constructed with expression vector pBj and human CD80 cDNA, using a lipofection method. CD80-transfected tumor cells (CD80-AT) significantly augmented the proliferation of autologous lymphocytes from all cases as compared with non-transfected tumor cells (AT). AT-stimulated lymphocytes from 4 out of 5 cases did not show any cytotoxicity against AT; however, lymphocytes stimulated with CD80-AT exhibited substantial cytotoxicity against parental AT in all 5 cases tested. AT-stimulated lymphocytes derived from only one out of 5 cases showed major histocompatibility complex (MHC)-class I-restricted cytokine production in response to AT, while the MHC-class I-restricted responses were found in CD80-AT-stimulated lymphocytes from 4 out of 5 cases. These results indicate that CD80 on tumor cells could be a beneficial costimulatory molecule to elicit CTL against lung cancer, and also show that TA recognized by CTL was frequently expressed on lung cancer cells.
Collapse
Affiliation(s)
- M Takenoyama
- Department of Surgery II, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Isei N, Isayama A, Ishida S, Sato M, Oikawa T, Fukuda T, Nagashima A, Iwama N. Electron cyclotron emission measurements in JT-60U. Fusion Engineering and Design 2001. [DOI: 10.1016/s0920-3796(00)00485-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Abstract
UNLABELLED A pericardial cyst is a rare condition in childhood. We report on a 10-year-old girl who presented with an intrathoracic mass detected on a chest X-ray performed during a routine medical examination. She had no symptoms and a physical examination revealed no abnormalities. Ultrasonography, computed tomography and magnetic resonance imaging showed a multiloculated cystic mass in the right upper thorax. The cyst was resected using a thoracoscopic procedure. Histologically, the findings were consistent with a pericardial cyst. Thoracoscopic surgery was an effective surgical technique even for such a young patient and the results successfully reduced the morbidity. CONCLUSION A pericardial cyst, a rare condition in childhood, was treated successfully by video-assisted thoracoscopic surgery.
Collapse
Affiliation(s)
- A Eto
- Department of Paediatric Surgery, Kitakyushu Municipal Medical Centre, Japan
| | | | | |
Collapse
|
31
|
Nagasaka Y, Nagashima A. Absolute measurement of the thermal conductivity of electrically conducting liquids by the transient hot-wire method. ACTA ACUST UNITED AC 2000. [DOI: 10.1088/0022-3735/14/12/020] [Citation(s) in RCA: 260] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
32
|
Kanamaru K, Fujiwara M, Kim M, Nagashima A, Nakazato E, Tanaka K, Takahashi H. Chloroplast targeting, distribution and transcriptional fluctuation of AtMinD1, a Eubacteria-type factor critical for chloroplast division. Plant Cell Physiol 2000; 41:1119-28. [PMID: 11148270 DOI: 10.1093/pcp/pcd037] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
In Arabidopsis thaliana, a mature mesophyll cell contains approximately 100 chloroplasts. Although 12 arc mutants (accumulation and replication of chloroplasts) and two chloroplast division genes homologous to eubacterial ftsZ have been isolated from A. thaliana, the molecular mechanism underlying the chloroplast division is still unclear. We characterized AtMinD1, a eubacterial minD homolog, for chloroplast division in A. thaliana. AtMinD1-green fluorescent protein targeted to the chloroplasts and possibly associated with the envelope membranes in vivo. During the seed germination, the AtMinD1 transcripts were accumulated twice, just after release from cold treatment and at the beginning of rapid greening, in similar fashion to AtFtsZs. Furthermore the transcript level in a severest chloroplast division mutant, arc6, was 3-5-fold higher than that in wild-type.
Collapse
Affiliation(s)
- K Kanamaru
- Institute of Molecular and Cellular Biosciences, The University of Tokyo, Japan
| | | | | | | | | | | | | |
Collapse
|
33
|
Fujiwara M, Nagashima A, Kanamaru K, Tanaka K, Takahashi H. Three new nuclear genes, sigD, sigE and sigF, encoding putative plastid RNA polymerase sigma factors in Aarabidopsis thaliana. FEBS Lett 2000; 481:47-52. [PMID: 10984613 DOI: 10.1016/s0014-5793(00)01965-7] [Citation(s) in RCA: 77] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Three new nuclear genes (sigD, sigE and sigF) of Arabidopsis thaliana, encoding putative plastid RNA polymerase sigma factors, were identified and analyzed. Phylogenetic analysis revealed that higher plant sigma factors fell into at least four distinct subgroups within a diverse protein family. In addition, Arabidopsis sig genes contained conserved chromosomal intron sites, indicating that these genes arose by DNA duplication events during plant evolution. Transcript analyses revealed two alternatively spliced transcripts generated from the sigD region, one of which is predicted to encode a sigma protein lacking the carboxy-terminal regions 3 and 4. Finally, the amino-terminal sequence of the sigF gene product was shown to function as a plastid-targeting signal using green fluorescent protein fusions.
Collapse
Affiliation(s)
- M Fujiwara
- Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, 113-0032, Japan
| | | | | | | | | |
Collapse
|
34
|
Hanagiri T, Muranaka H, Hashimoto M, Nagashima A. A syndrome of inappropriate secretion of antidiuretic hormone associated with pleuritis caused by OK-432. Respiration 2000; 65:310-2. [PMID: 9730800 DOI: 10.1159/000029283] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
We here report a case presenting with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after having been treated for pleurodesis with OK-432, which is a lyophilized preparation of an attenuated strain of Streptococcus pyogenes. The patient, who had undergone a subtotal esophagectomy 4 years previously, was referred to our department after the diagnosis of a metastatic lung tumor. A right lower lobectomy of the lung was performed, and prolonged air leakage from a pulmonary fistula thereafter developed because of the dissection of severe pleural adhesion. OK-432 (5 klinische einheiten) was administered to the pleural cavity 3 times. On the 13th postoperative day, the patient began to complain of general fatigue and nausea. SIADH was diagnosed based on laboratory findings such as hyponatremia, serum hypo-osmolality and a high excretion of sodium in the urine. A restriction of the fluid intake with a sodium supplement resulted in the return to a normal serum level within 2 weeks. We therefore concluded that the intrapleural instillation of OK-432 had apparently caused SIADH in this case, because no other causes could be found.
Collapse
Affiliation(s)
- T Hanagiri
- Department of Chest Surgery, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
| | | | | | | |
Collapse
|
35
|
Abstract
In making an artificial esophagus, the transplantation of the epithelialized granulation tube fabricated by organized synthetic material was studied mainly from the viewpoint of preventing anastomotic leakage and stricture formation. The possibility of epithelialization of the inner surface of a granulation tube using cultured epidermal cells was studied in rats and dogs. A stainless steel mesh tube coated with silicon served as the granulation tube. Epithelialization on the inner surface of a granulation tube was evaluated by seeding cultured epidermal cells. A skin sample was treated with dispase and trypsin to collect epidermal cells, which were cultured in a keratinocyte growth medium. Once confluence was achieved, the epidermal cell suspension was harvested using the following methods: trypsin treatment (n = 15), mechanical separation with a cell scraper (n = 6), and dispase treatment (n = 9). The cultured epidermal cell suspension was then seeded into the lumen of the granulation tubes. The attachment of cultured epidermal cells was attained in 2 of 15 cases by trypsin treatment, and in 5 of 9 cases by dispase treatment. No attachment occurred using the cell scraper method. All attached epidermal cells exhibited a cobblestone appearance on the granulation tissue with a tendency toward stratification. These findings show that the inner surface of a steel mesh granulation tube was epithelialized by cultured epidermal cells.
Collapse
Affiliation(s)
- A Nagashima
- Department of Surgery, School of Medicine, Keio University, Tokyo, Japan
| | | | | | | | | |
Collapse
|
36
|
Kanai H, Kashiwagi M, Hirakata H, Nagashima A, Tada S, Yao T, Nakamoto M, Nakamura S, Fujishima M. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient. Clin Nephrol 2000; 53:394-9. [PMID: 11305814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023] Open
Abstract
Dialysis-related amyloidosis (DRA) is one of the most serious complications interfering with rehabilitation in dialysis patients. Here, we report a case of beta2-microglobulin (beta2M)-related amyloidosis, in which the patient developed a severe intestinal pseudo-obstruction. The patient was a 42-year-old male who had been undergoing hemodialysis for 13 years, and who had no history of osteoarticular involvement of DRA. The first symptoms of the disease were severe abdominal fullness and nausea after meals. The whole intestinal wall biopsy revealed massive amyloid deposition in the propria muscularis. The patient became malnourished and died of acute subendocardial infarction 3 years after the onset. An autopsical examination revealed a massive deposition of amyloid, which was positively stained with anti-beta2M antibody but not AA amyloid, predominantly in the gastrointestinal muscular layer, including the tongue, esophagus, stomach, small intestines, colon, and rectum. These results suggest that the gastrointestinal involvement of beta2M-related amyloidosis might occur during the course of hemodialysis treatment, and that this possibility should be considered if patients suffer from intestinal pseudo-obstruction without osteoarticular symptoms.
Collapse
Affiliation(s)
- H Kanai
- The Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Abstract
In the present study, we reviewed the patients who developed bone metastases after a surgical resection of primary lung cancer and evaluated their clinicopathological features. From 1992 to 1995, 177 patients with stage I and II primary lung cancer underwent a surgical resection at the Kitakyushu Municipal Medical Center. Bone metastases were detected in 14 patients (7.9%) by follow-up examinations including bone scintigraphy (scan). Bone metastasis was one of the most frequent extra-thoracic recurrent forms. Patients with adenocarcinoma tended to develop bone metastases more frequently than those with squamous cell carcinoma. In the preoperative bone scans, an abnormal uptake was observed in 76 patients (42.9%), and 10 (13.1%) of them were found to develop bone metastases in the follow-up studies. A microscopic examination of the primary tumor demonstrated close correlation between intratumoral and peritumoral lymphatic vessel invasion and postoperative development of bone metastases. A bone scan is a very useful and indispensable procedure for diagnosing bone metastases. However, this scan may also show false positive finding in a number of benign conditions. Therefore, a surgical resection should be considered as the first-line treatment for patients with positive findings in the bone scan when the diagnosis of bone metastasis can not be confirmed based on both their symptoms and other clinical examinations.
Collapse
Affiliation(s)
- T Hanagiri
- Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, Japan
| | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
Parathyroid cysts are rarely located in the mediastinum. This report describes a 45-year-old man with a mediastinal parathyroid cyst. Video-assisted thoracic surgery was successfully performed to remove the cyst.
Collapse
Affiliation(s)
- T Oyama
- Department of Surgery 2, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | | | | | | | | |
Collapse
|
39
|
Kontani H, Jinkawa M, Shiraoya C, Nagashima A. Effect of K+ channel openers, KRN2391 and Ki1769, and nitroglycerin on the urinary tract of rats in vivo. Jpn J Pharmacol 1999; 80:143-53. [PMID: 10440533 DOI: 10.1254/jjp.80.143] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
The effects of KRN2391 (N-cyano-N'-(nitroxyethyl)-3-pyridine carboximidamide methane-sulfonate), which possesses ATP-sensitive potassium (K+) channel opening (KCO) activity and nitrate activity; Ki1769 (N-cyano-N'-(phenylethyl)-3-pyridinecarboximidamide methanesulfonate), which possesses only KCO activity; and nitroglycerin (NG) were determined on the motility of the ureter, urinary bladder and urethra of rats. Bladder contraction was induced by infusion of fluid into the bladder of conscious rats and recorded on a cystometrogram. KRN2391 and Ki1769 (both 0.3 mg/kg, i.v.) prolonged the micturition interval immediately after the injection, but NG (5 mg/kg, i.v.) did not. Peristaltic movement of the ureter, recorded in anesthetized rats, was inhibited by i.v. injection of KRN2391 and Ki1769 (both 0.03 mg/kg). However, when NG, NaNO2, N-nitro L-arginine methylester and methylene blue were applied directly to the ureter, no change in movement of the ureter was detected. KRN2391 (0.03 mg/kg, i.v.) and Ki1769 (0.3 mg/kg, i.v.) reduced the resistance to fluid infusion through the urethral lumen in anesthetized rats, whereas NG (0.5 mg/kg, i.v.) only reduced this resistance transiently. These results indicate that KCO activity had an inhibitory effect on the motility of the ureter, bladder and urethra. On the other hand, nitrate activity had an inhibitory effect on urethral tonus, corresponding to that induced by KCO activity.
Collapse
Affiliation(s)
- H Kontani
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
| | | | | | | |
Collapse
|
40
|
Kaseda S, Aoki T, Yamamoto S, Nagashima A, Ukai I, Satoh K. Successful simultaneously stapled lobectomy for a stab wound to the lung with massive hemorrhage: case report. J Trauma 1999; 46:1140-1. [PMID: 10372643 DOI: 10.1097/00005373-199906000-00036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- S Kaseda
- Department of Thoracic Surgery, Saiseikai Kanagawa-ken Hospital, Yokohama, Japan.
| | | | | | | | | | | |
Collapse
|
41
|
Masuda M, Toriya Y, Ihara T, Abe R, Nagashima A, Komiyama S. Stomal recurrence invading the cervicothoracic esophagus and upper mediastinum: resectability and the creation of a safe anterior mediastinal tracheostoma. Eur Arch Otorhinolaryngol 1999; 256 Suppl 1:S70-2. [PMID: 10337532 DOI: 10.1007/pl00014159] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Surgical salvage for stomal recurrence is a for midable problem for head and neck surgeons. The two factors of considerable significance are resectability and establishment of a safe anterior mediastinal tracheostoma. A case of stomal recurrence invading the cervicothoracic esophagus and upper mediastinum is presented. Total esophagectomy and upper mediastinal dissection was performed. The esophagus was reconstructed immediately with a pedicled gastric flap. The omentum on the gastric pedicle was wrapped around the trachea to reduce the likelihood of erosion into the great vessels and to supplement the lateral blood supply to the trachea. No serious postoperative complications were observed. We believe that the total esophagectomy improved the resectability, and that the bulk of the gastric pedicle and the use of the omentum prevented significant postoperative complications associated with an anterior mediastinal tracheostoma.
Collapse
Affiliation(s)
- M Masuda
- Department of Otorhinolaryngology, Faculty of Medicine, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | |
Collapse
|
42
|
Yabuuchi H, Murayama S, Sakai S, Hashiguchi N, Murakami J, Muranaka T, Soeda H, Sugio K, Nagashima A, Masuda K. Resected peripheral small cell carcinoma of the lung: computed tomographic-histologic correlation. J Thorac Imaging 1999; 14:105-8. [PMID: 10210482 DOI: 10.1097/00005382-199904000-00007] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
In order to clarify the characteristic computed tomographic findings of peripheral small cell lung cancer, the authors investigated 12 patients with surgically resected and histologically proven peripheral small cell lung cancer. Conventional computed tomography was performed on all, and additional high-resolution computed tomographic images were obtained for nine patients. Marginal, internal, and surrounding features of the tumors were analyzed, and these findings were correlated with histologic findings. All 12 tumors appeared as homogenous masses, and eight had well-defined margins. Lobulation was found in seven, marginal ground-glass opacity in three, fine spiculation in two, and both ground-glass opacity and spiculation in one. Cut specimens showed whitish medullary masses without large areas of necrosis, and microscopic specimens showed small areas of necrosis in 11 patients. Marginal ground-glass opacities corresponded to focal edema and hemorrhage in two patients and to intraalveolar invasion in one. Fine spiculation corresponded to vascular/lymphatic invasion in one patient and to irregular intraalveolar spread in another. The authors concluded that a homogenous mass without necrosis is the most characteristic feature of peripheral small cell carcinoma on computed tomography.
Collapse
Affiliation(s)
- H Yabuuchi
- Department of Radiology, Kyushu University, Fukuoka, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Abstract
The treatment of potentially resectable lung cancer in octogenarians has become a frequent clinical problem, due to the increasing number of elderly people maintaining an active daily life. In the present study, we reviewed the clinical records of patients to evaluate the results of the surgical treatment of lung cancer in octogenarians. From 1992 to 1995, 18 patients aged 80 years or older (octogenarians) with primary lung cancer underwent surgical resections including: three (16.7%) sleeve lobectomies, nine (50.0%) lobectomies, one (5.5%) segmentectomy, and five (27.8%) partial resections. The postoperative complication rate was 50% in octogenarians; however, no fatal complications were observed. The 5-year survival rate was 42.6%, which was similar to that obtained in younger patients. Based on our findings, the surgical treatment of lung cancer can thus be performed in selected octogenarians without increasing either morbidity or mortality, while also obtaining long-term survival.
Collapse
Affiliation(s)
- T Hanagiri
- Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
| | | | | | | | | |
Collapse
|
44
|
Yoshii H, Sato M, Yamamoto S, Motegi M, Okusawa S, Kitano M, Nagashima A, Doi M, Takuma K, Kato K, Aikawa N. Usefulness and limitations of ultrasonography in the initial evaluation of blunt abdominal trauma. J Trauma 1998; 45:45-50; discussion 50-1. [PMID: 9680011 DOI: 10.1097/00005373-199807000-00009] [Citation(s) in RCA: 126] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND In the assessment of blunt abdominal trauma, the reliability of ultrasonography (US) in identifying individual organ injuries remains uncertain, in spite of its usefulness in detecting hemoperitoneum. This study was designed to evaluate the overall diagnostic value of US, including identification of individual organ injuries. METHODS The accuracy of US in the detection of intra-abdominal injuries and the identification of individual organ injuries was evaluated in 1,239 patients seen during a 15-year period. Accuracy was based on detection of intraperitoneal fluid, free air, or irregular parenchymal lesions. RESULTS For the detection of injuries, US was 94.6% sensitive, 95.1% specific, and 94.9% accurate. Individual organ injuries were identified with sensitivities of 92.4, 90.0, 92.2, 71.4, and 34.7% for the liver, spleen, kidneys, pancreas, and intestine, respectively. CONCLUSION US is reliable for the detection of injuries and the identification of solid-organ injuries despite its poor sensitivity for intestinal injuries.
Collapse
Affiliation(s)
- H Yoshii
- Department of Surgery, Saiseikai Kanagawaken Hospital, Yokohama, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Kaseda S, Hangai N, Aoki T, Yamamoto S, Nagashima A, Harada N, Satoh K. Successful emergency right pneumonectomy for deep laceration of the lung: case report. J Trauma 1998; 44:918-9. [PMID: 9603100 DOI: 10.1097/00005373-199805000-00030] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- S Kaseda
- Department of Thoracic Surgery, Saiseikai Kanagawa-ken Hospital, Kanagawa-ken Traffic Trauma Center, Yokohama, Japan
| | | | | | | | | | | | | |
Collapse
|
46
|
Hanagiri T, Yoshino I, Takenoyama M, So T, Fujie H, Imabayashi S, Eifuku R, Yoshimatsu T, Osaki T, Nakanishi R, Ichiyoshi Y, Nagashima A, Nomoto K, Yasumoto K. Effects of interleukin-12 on the induction of cytotoxic T lymphocytes from the regional lymph node lymphocytes of patients with lung adenocarcinoma. Jpn J Cancer Res 1998; 89:192-8. [PMID: 9548447 PMCID: PMC5921758 DOI: 10.1111/j.1349-7006.1998.tb00548.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Lung cancer-specific cytotoxic T lymphocytes (CTL) were induced by repeated stimulations of regional lymph node lymphocytes (RLNL) in lung cancer patients with either autologous or HLA-A-locus-matched tumor cells. To investigate the effect of interleukin-12 (IL-12), IL-12 was added during the stimulation of RLNL from HLA A24/adenocarcinoma patients with either autologous tumor cells or HLA A24-positive adenocarcinoma cells (PC-9) in combination with, or instead of interleukin-2 (IL-2), and then the cytotoxic activity, cytokine production and populations of the lymphocyte subsets were examined. The addition of IL-12, or the substitution of IL-2 by IL-12 was found to enhance the cytotoxic activity and the cytokine production (IFN-gamma, GM-CSF) of the CTL as compared with IL-2 alone. The cytotoxic activity and cytokine production were both partially inhibited by anti-MHC-class I monoclonal antibody. The CTL thus induced by IL-12 had a higher proportion of CD3+/CD56+ cells than the CTL induced with IL-2 alone. The positively selected CD8+/CD56- lymphocytes showed PC-9-specific cytotoxic activity, because the population did not show any cytotoxicity to K562 or A549 (HLA-A26/A30). However, the CD3+/CD56+ lymphocytes were cytotoxic to both PC-9 and K562. In conclusion, IL-12 is considered to be a useful cytokine for both the induction of lung-cancer specific CTL and the augmentation of non-MHC-restricted cytotoxicity against tumor cells, and may be applicable for adoptive immunotherapy using CTL.
Collapse
Affiliation(s)
- T Hanagiri
- Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Kitakyushu
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Abstract
We herein report the successful surgical treatment of 2 cases of chronic expanding hematoma in the chest. The first patient, who had undergone thoracoplasty 42 years earlier due to tuberculosis, became aware of a slowly growing mass protruding in the lateral thoracic wall. The second patient, who had tuberculous pleurisy 36 years earlier, was referred to our department because of a slowly expanding intrathoracic mass revealed by a roentgenogram. The tumors, which were encapsulated chronic hematomas, were both surgically resected. These cases are rare because of the development of a very large mass after undergoing treatment for tuberculosis more than 30 years previously.
Collapse
Affiliation(s)
- T Hanagiri
- Department of Chest Surgery, Kitakyushu Municipal Medical Center, Japan
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Hatae T, Nagashima A, Yoshida H, Naito O, Kitamura S, Yamashita O, Kazama D, Onose Y, Matoba T. First operation results of YAG laser Thomson scattering system on JT-60U. Fusion Engineering and Design 1997. [DOI: 10.1016/s0920-3796(96)00587-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Nagashima A, Gamou Y, Terai M, Wakabayashi M, Oshima C. Electronic states of the heteroepitaxial double-layer system: Graphite/monolayer hexagonal boron nitride/Ni(111). Phys Rev B Condens Matter 1996; 54:13491-13494. [PMID: 9985255 DOI: 10.1103/physrevb.54.13491] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
50
|
Kanai H, Hirakata H, Nakayama M, Nagashima A, Fujishima M. Minimal daily variations of plasma and urinary endothelin-1 in healthy subjects. Clin Nephrol 1996; 46:353-4. [PMID: 8953127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
The daily profiles of both the plasma level and the urinary excretion rate of endothelin-1 were examined in 13 healthy volunteers (9 males and 4 females, aged 22 +/- 1 [SEM]). Plasma endothelin-1 (PET) was measured after a one-hour recumbency every 6 hours at 8 a.m., 2 p.m., 8 p.m. and 2 a.m. and the urinary excretion rate of endothelin-1 (UET) was determined in the urine collected every 6 hours. PET was found to be quite stable throughout the day, being 1.57 +/- 0.25 pg/ml at 8 a.m., 1.88 +/- 0.21 at 2 p.m., 2.2 +/- 0.24 at 8 p.m. and 1.90 +/- 0.20 at 2 a.m. After a one-hour ambulation, PET showed no statistical difference. UET also remained unchanged for each 6-hour collecting period, measuring 4.61 +/- 0.69, 3.98 +/- 0.46, 4.63 +/- 0.73 and 3.42 +/- 0.49 ng/hr, respectively. The absence of any daily variations in either PET or UET thus suggests that apparently no specific considerations need be applied regarding the time of taking samples to measure the plasma and urinary endothelin-1.
Collapse
Affiliation(s)
- H Kanai
- Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka City, Japan
| | | | | | | | | |
Collapse
|